Suggestions
Emily Chee
General Manager, US at Novartis Gene Therapies (formerly AveXis)
Professional Background
Emily Chee is a highly accomplished commercial executive with two decades of extensive experience in the pharmaceutical industry. Throughout her illustrious career, she has demonstrated a performance-driven approach, particularly known for building and leading high-impact commercial teams. Emily has effectively collaborated with Medical and Development teams, resulting in numerous successful projects and initiatives that have significantly advanced the organizations she has represented. Her broad commercial experience encompasses key areas such as marketing, sales management, account management, product launches, business analytics, thought leader engagement, market access, and companion diagnostics, illustrating her versatility in the field.
Currently, Emily serves as the General Manager, US at Novartis Gene Therapies. In this role, she leverages her vast knowledge and strategic expertise to drive the growth and development of gene therapies within the U.S. market. Her deep understanding of market dynamics, regulatory considerations, and patient needs empowers her to develop impactful strategies that enhance access to groundbreaking treatments.
Prior to her current position, Emily held multiple senior roles within Novartis Oncology, including Executive Business Director positions focusing on Sickle Cell Disease and Solid Tumors, where she was instrumental in launching and promoting therapies that significantly improve the lives of patients. As Senior Brand Director for key products such as Tafinlar + Mekinist and Votrient, she played a crucial role in brand strategy and execution, showcasing her marketing prowess and ability to align complex scientific data with market needs.
Education and Achievements
Emily's academic background includes an MBA from the prestigious Ivey Business School at Western University, where she honed her leadership and business acumen. Additionally, she earned a Bachelor of Science in Pharmacy from The University of British Columbia, laying the foundation for her career in the healthcare sector. This combination of rigorous education and practical experience has uniquely positioned her to understand both the clinical and commercial aspects of pharmaceutical development and patient care.
Her career trajectory has also been marked by significant positions at Novartis Oncology, where she held roles such as Director, Global Integration Brand Team for Melanoma, and Director of CML Molecular Diagnostics. Emily's influence can be seen through her contributions to integrated marketing strategies and development initiatives aimed at rare and complex disease states. She has consistently exceeded expectations and delivered results that align with corporate objectives, positioning her as a leader in the competitive landscape of oncology.
In her earlier career, Emily transitioned from roles in sales and marketing to strategic positions that involved cross-functional teamwork and a deepened focus on market access and managed care. This journey included key positions as an Area Sales Manager at Novartis Oncology and Manager at ZS Associates, where she developed a robust understanding of market dynamics and influence strategies in healthcare.
Furthermore, Emily's early experience as a Pharmacist at Shoppers Drug Mart equipped her with an invaluable perspective on patient needs and pharmacy operations, further enriching her insights into the pharmaceutical business. This breadth of experience across the pharmaceutical value chain enhances her capability to navigate complex challenges and fuel growth in organizations.
Achievements
Emily Chee has continually been recognized for her contributions to the pharmaceutical industry. Some of her notable achievements include leading successful product launches that have introduced innovative therapies to the market, thereby impacting patient outcomes positively. Her collaborative spirit and ability to engage thought leaders have resulted in fruitful partnerships that enhance knowledge sharing and elevate brand visibility within targeted therapeutic areas.
As a visionary leader, Emily is passionate about expanding access to life-saving treatments and fostering inclusive practices within commercial operations. Her strategic insights and commitment to excellence have earned her respect and recognition among peers and industry stakeholders alike. Emily's focus on empowering her teams not only achieves remarkable results but also cultivates a culture of innovation and accountability.
In conclusion, Emily Chee embodies the attributes of a passionate and effective commercial executive dedicated to making a meaningful impact in the pharmaceutical space. With her rich experience, leadership capabilities, and unwavering commitment to advancing healthcare solutions, she is poised to continue driving positive change in the industry and contributing to the well-being of patients.
tags=[